Design of KYSA-6, a Phase 2, Open-Label, Multicenter Study of KYV-101, a Novel Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Refractory Generalized Myasthenia Gravis

被引：0
|
作者：
Haghikia, Aiden [1 ]
Borie, Dominic [2 ]
Chung, James [2 ]
Gold, Ralf [3 ]
机构：
[1] Otto von Guericke Univ, Fac Med, Dept Neurol, Magdeburg, Germany
[2] Kyverna Therapeut Inc, Emeryville, CA USA
[3] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1628/1868
引用
收藏
页码：1031 / 1032
页数：2
相关论文
共 50 条
  • [1] DESIGN OF KYSA-6, A PHASE 2, OPEN-LABEL, MULTICENTER STUDY OF KYV-101, A NOVEL FULLY HUMAN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN REFRACTORY GENERALIZED MYASTHENIA GRAVIS
    Haghikia, Aiden
    Borie, Dominic
    Chung, James
    Gold, Ralf
    MUSCLE & NERVE, 2024, 70 (03) : 542 - 542
  • [2] Design of KYSA-7, A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Treatment Refractory Primary and Secondary Progressive Multiple Sclerosis
    Dunn, Jeffrey
    Friese, Manuel
    Cree, Bruce A. C.
    Smith, Marshelle Warren
    Qu, Kunbin
    Borie, Dominic
    Chung, James
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1008 - 1008
  • [3] Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy
    Dai, Zhenyu
    Hu, Xuelian
    Jia, Xiangyin
    Liu, Jianwei
    Yang, Yongkun
    Niu, Panpan
    Hu, Guang
    Tan, Taochao
    Zhou, Jianfeng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) : 5832 - 5847
  • [4] Anti-CD19 chimeric antigen receptor T-cell therapy for Richter′s transformation: a multicenter retrospective study
    Kittai, Adam
    Bond, David
    Huang, Ying
    Bhat, Seema
    Blyth, Emily
    Byrd, John
    Chavez, Julio
    Davids, Matthew
    Dela Cruz, Jamie
    Dowling, Mark
    Duffy, Caitlyn
    Ho, Carrie
    Jacobson, Caron
    Jaglowski, Samantha
    Jain, Nitin
    Lin, Kevin
    McCarthy, Christine
    Parry, Erin
    Rai, Manoj
    Rogers, Kerry
    Saha, Aditi
    Schachter, Levanto
    Scott, Hamish
    Shadman, Mazyar
    Siddiqi, Tanya
    Stephens, Deborah M.
    Vanguru, Vinay
    Wierda, William
    Zulfa, Omer
    Woyach, Jennifer
    Thompson, Phillip
    LEUKEMIA & LYMPHOMA, 2023, 64 : S85 - S86
  • [5] Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
    Kittai, Adam S.
    Bond, David
    Huang, Ying
    Bhat, Seema A.
    Blyth, Emily
    Byrd, John C.
    Chavez, Julio C.
    Davids, Matthew S.
    Dela Cruz, Jamie P.
    Dowling, Mark R.
    Duffy, Caitlyn
    Ho, Carrie
    Jacobson, Caron
    Jaglowski, Samantha
    Jain, Nitin
    Lin, Kevin H.
    Miller, Cecelia
    Mccarthy, Christine
    Omer, Zulfa
    Parry, Erin
    Rai, Manoj
    Rogers, Kerry A.
    Saha, Aditi
    Schachter, Levanto
    Scott, Hamish
    Senapati, Jayastu
    Shadman, Mazyar
    Siddiqi, Tanya
    Stephens, Deborah M.
    Vanguru, Vinay
    Wierda, William
    Woyach, Jennifer A.
    Thompson, Philip A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17) : 2071 - 2079
  • [6] Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter's Transformation: An International Multicenter Retrospective Study
    Kittai, Adam S.
    Bond, David A.
    Huang, Ying
    Bhat, Seema A.
    Blyth, Emily
    Byrd, John C.
    Chavez, Julio C.
    Davids, Matthew S.
    Dela Cruz, Jamie P.
    Dowling, Mark R.
    Duffy, Caitlyn
    Ho, Carrie I.
    Jacobson, Caron A.
    Jaglowski, Samantha M.
    Jain, Nitin
    Lin, Kevin H.
    McCarthy, Christine
    Parry, Erin M.
    Rai, Manoj
    Rogers, Kerry A.
    Saha, Aditi
    Schachter, Levanto
    Scott, Hamish
    Senapati, Jayastu
    Shadman, Mazyar
    Siddiqi, Tanya
    Stephens, Deborah M.
    Vanguru, Vinay
    Wierda, William G.
    Zulfa, Omer
    Woyach, Jennifer A.
    Thompson, Philip A.
    BLOOD, 2023, 142
  • [7] Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study
    Tun, Aung M.
    Patel, Romil D.
    St-Pierre, Frederique
    Ouchveridze, Evguenia
    Niu, Alex
    Thordardottir, Thorunn
    Obasi, Jennifer
    Rosenthal, Allison
    Pophali, Priyanka A.
    Fenske, Timothy S.
    Karmali, Reem
    Ahmed, Sairah
    Johnston, Patrick B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1712 - 1720
  • [8] Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
    Fried, Shalev
    Shkury, Eden
    Itzhaki, Orit
    Sdayoor, Inbal
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Danylesko, Ivetta
    Jacoby, Elad
    Shouval, Roni
    Kedmi, Meirav
    Marcus, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    Avigdor, Abraham
    LEUKEMIA & LYMPHOMA, 2023, 64 (12) : 1956 - 1963
  • [9] Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach
    Saifi, Omran
    Lester, Scott
    Breen, William
    Rule, William
    Lin, Yi
    Bennani, N. Nora
    Rosenthal, Allison
    Munoz, Javier
    Murthy, Hemant
    Kharfan-Dabaja, Mohamed
    Peterson, Jennifer
    Hoppe, Bradford
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (01) : 124 - 134
  • [10] A Phase I Clinical Trial of Fully Human Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
    Cooper, Brenda W.
    Gallogly, Molly Megan
    Metheny, Leland
    Klisovic, Rebecca B.
    Boughan, Kirsten Marie
    Koc, Jane Reese
    Wu, Darong
    Deng, Changchun
    Van Besien, Koen
    Tupta, Rose
    Schneider, Dina
    Ciarrone, Lisa
    de Lima, Marcos
    Caimi, Paolo F.
    Tomlinson, Benjamin K.
    BLOOD, 2023, 142
12345